Digital pathology is a field of pathology that emphases on data management based on information generated from digitized specimen slides. It incorporates the management, acquisition, sharing & interpretation of pathology information including data and slides in a digital environment. Digital slides are formed when glass slides are captured through a scanning device, to provide a high-resolution digital image that can be observed on a computer screen or mobile device.
According to study, “Global Digital Telepathology Market Status (2015-2019) and Forecast (2020-2024) by Region, Product Type & End-Use” some companies operating in the global digital telepathology market are Olympus Corporation, Ventana Medical Systems, Inc., Koninklijke Philips N.V., Diagnostic Instruments Inc., Mikroscan Technologies, Inc., Leica Biosystems Nussloch GmbH, GE Healthcare, eVisit Telemedicine Solution, Teleconsult Europe, Unilabs. Key companies are focusing on emergent digital pathology scanners with enhanced resolution, high magnification, high throughput, and high-end microscopes using automated scanning, all of which are anticipated to drive the market growth during the forecast period.
Based on type, digital telepathology market is segmented into veterinary pathology and human pathology. Human pathology segment holds major share in market owing to rise in number of cancer research activities and growth in collaborations between universities, academic research institutes, and pathology laboratories. Based on product type, market is segmented into scanners, communication systems, software, and storage system. The software segment is anticipated to witness the highest growth rate due to rise in availability of analytical, user-friendly, and advanced functions for pathology diagnosis during the forecast period. Based on technology, market is segmented into telepathology and whole side imaging technology. Based on application, market is segmented into drug discovery, teleconsultation, training & education, disease diagnosis (cancer cell detection) and others. The teleconsultation segment is anticipated to exhibit substantial growth rate as a result of increase in need for quality & fast diagnosis and shortage of pathologists in developing countries during the forecast period. In addition, based on end-user, market is segmented into hospitals, pharmaceutical & biotech companies, diagnostic centers & pathology clinics, academic institutes and research organizations etc.
The digital telepathology market is driven by rise in prevalence of cancer, followed by ease of consultation enabled by digital pathology, growth in adoption of digital pathology to enhance lab efficiency, increase in initiatives by governments & industry players and growth in applications of digital pathology in drug development or companion diagnostics. However, lack of standard guidelines and high cost of digital pathology systems may impact the market. Moreover, integration of digital pathology systems and Laboratory Information Systems (LIS) and introduction of affordable scanners for private pathology practices are key opportunities for market. Furthermore, rise in digitalization and information technology across the globe is a major trend for market.
Based on geography, the North-American region holds major share in digital telepathology market owing to rise in prevalence of chronic diseases and increase in government initiatives in the region. Whereas, the European and Asian-Pacific regions are exhibit higher growth rate due to growth in healthcare expenditure and increase in awareness related to digital pathology systems over the forecast period. In upcoming years, it is projected that future of the market will be bright on account of rise in awareness pertaining to the benefits of using Computer-Aided Diagnostics (CAD) and growth in fiscal stability during the forecast period.
For More Information, Click on the Link Below:-
Ankur Gupta, Head Marketing & Communications